论文信息 - A phase II study of bevacizumab with modified OPTIMOX1 as first-line therapy for metastatic colorectal cancer: the TCOG-GI 0802 study - 字舞流文

A phase II study of bevacizumab with modified OPTIMOX1 as first-line therapy for metastatic colorectal cancer: the TCOG-GI 0802 study

K. Hibi | T. Sekikawa | Soichi Tanaka | N. Nakayama | K. Konishi | K. Hayashi | A. Sato | T. Sakuyama | K. Shimada | E. Sasaki | H. Ichikawa | Y. Kikuchi | H. Nishina | Tokyo Japan The Tokyo Cooperative Oncology Group | Yoshinori Kikuchi